Literature DB >> 23556064

Pancreatic insulinoma combined with glucagon positive cell: A case report.

Suguru Yamashita1, Nobutaka Tanaka, Michiro Takahashi, Motoki Nagai, Takatoshi Furuya, Yoshio Suzuki, Yukihiro Nomura.   

Abstract

We present a 70-year-old man who was referred for surgery with uncontrollable hypoglycemia. Ultrasonography and abdominal contrast computed tomography revealed a hypervascular tumor of 1 cm in diameter in the pancreatic tail. With a diagnosis of insulinoma, we performed a distal pancreatectomy. The patient showed a good postoperative course without any complications. The patient's early morning fasting hypoglycemia disappeared. The respective levels of C-peptide and insulin dropped from 14.9 ng/mL and 4860 μIU/mL preoperatively to 5.3 ng/mL and 553 μIU/mL after surgery. A histopathological examination demonstrated that the tumor was a pancreatic neuroendocrine tumor, grade 1. Immunostaining was negative for insulin and positive for CD56, chromogranin A, synaptophysin and glucagon. These findings suggested that the tumor was clinically an insulinoma but histopathologically a glucagonoma. Among all insulinoma cases reported between 1985 and 2010, only 5 cases were associated with independent glucagonoma. In this report, we characterize and discuss this rare type of insulinoma by describing the case we experienced in detail.

Entities:  

Keywords:  Glucagon; Hypoglycemia; Insulinoma; Neuroendocrine tumor; Pancreas

Year:  2013        PMID: 23556064      PMCID: PMC3615307          DOI: 10.4240/wjgs.v5.i3.68

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  21 in total

1.  Well-differentiated pancreatic tumor/carcinoma: insulinoma.

Authors:  Wouter W de Herder; Bruno Niederle; Jean-Yves Scoazec; Stanislas Pauwels; Gunter Kloppel; Massimo Falconi; Dik J Kwekkeboom; Kjel Oberg; Barbro Eriksson; Bertram Wiedenmann; Guido Rindi; Dermot O'Toole; Diego Ferone
Journal:  Neuroendocrinology       Date:  2007-02-20       Impact factor: 4.914

Review 2.  [Insulinoma--a statistical review of 358 cases of insulinoma reported from 1991 to 2000 in Japan].

Authors:  Y Tsuzuki; H Ishii
Journal:  Nihon Rinsho       Date:  2001-12

3.  Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems.

Authors:  Ewa Pomianowska; Ivar P Gladhaug; Krzysztof Grzyb; Bård I Røsok; Bjørn Edwin; Deidi S Bergestuen; Oystein Mathisen
Journal:  Scand J Gastroenterol       Date:  2010-08       Impact factor: 2.423

4.  Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover.

Authors:  Juris J Meier; Alexandra E Butler; Ryan Galasso; Peter C Butler
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

5.  Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

6.  Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.

Authors:  P F Quaedvlieg; O Visser; C B Lamers; M L Janssen-Heijen; B G Taal
Journal:  Ann Oncol       Date:  2001-09       Impact factor: 32.976

Review 7.  Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1.

Authors:  Jeffrey A Norton; Tony D Fang; Robert T Jensen
Journal:  J Natl Compr Canc Netw       Date:  2006-02       Impact factor: 11.908

8.  Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome.

Authors:  L I Larsson; T Schwartz; G Lundqvist; R E Chance; F Sundler; J F Rehfeld; L Grimelius; J Fahrenkrug; O Schaffalitzky de Muckadell; N Moon
Journal:  Am J Pathol       Date:  1976-12       Impact factor: 4.307

Review 9.  Neuroendocrine tumors of the pancreas.

Authors:  Florian Ehehalt; Hans D Saeger; C Max Schmidt; Robert Grützmann
Journal:  Oncologist       Date:  2009-05-01

10.  Beta-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform.

Authors:  Oscar Escribano; Carlos Guillén; Carmen Nevado; Almudena Gómez-Hernández; C Ronald Kahn; Manuel Benito
Journal:  Diabetes       Date:  2009-01-09       Impact factor: 9.461

View more
  1 in total

1.  Glucagonoma and the glucagonoma syndrome.

Authors:  Xujun Song; Suli Zheng; Gang Yang; Guangbing Xiong; Zhe Cao; Mengyu Feng; Taiping Zhang; Yupei Zhao
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.